Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications.
Andrew S MikhailAyele H NegussieMichal Mauda-HavakukJoshua W OwenWilliam F PritchardAndrew L LewisBradford J WoodPublished in: Expert opinion on drug delivery (2021)
TACE has been performed for nearly four decades by injecting chemotherapy drugs into the arterial supply of tumors while simultaneously cutting off their blood supply, trying to starve and kill cancer cells, with varying degrees of success. The practice has evolved over the decades but has yet to fulfill the promise of truly personalized therapies envisioned through rational selection of drugs and real-time multi-parametric image guidance to target tumor clonality or heterogeneity. Recent technologic and pharmacologic developments have opened the door for potentially groundbreaking advances in how TACE with DEE microspheres is performed with the goal of achieving advancements that benefit patients.